FGFR2 and neoplasm: While FGFR2-amplified tumor cells accounted for 10–20% of cells in 3/4 primary tumors and were mainly found in the central tumor area, up to 90% of the infiltrating tumor cells counted were evenly distributed in the center and periphery in 1/4 primary tumors (75% intratumoral heterogeneity).